Audrey:

 What's the base?

Charlie

-----Original Message-----
From: Audrey Buck [mailto:xxxxxx@POBOX.UPENN.EDU]
Sent: Thursday, February 01, 2001 11:36 AM
To: xxxxxx@HRINET.ORG
Subject: Re: [RESADM-L] Clinical Trial F&A Rates

Penn uses 23.6%.

Audrey

At 10:36 AM 02/01/2001 -0500, you wrote:
>Colleagues (especially colleagues at AAU Institutions):
>
>        In what has become an annual rite for this group, I would
appreciate
>it if you would let me know what your institution's F&A (indirect cost)
rate
>is for clinical trials and against what base the rate is charged (i.e. TDC,
>MTDC).
>        As has been the case for previous requestors of this data, I will
>compile it and make it available to all who are interested. ;-)
>        Thanks.
>
>Charlie
>
>Charles Kaars
>Assistant Vice President
>xxxxxx@research.buffalo.edu
>voice:716-645-2977 ext. 101
>fax:716-645-3730
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
Audrey C. Buck
Senior Contract Administrator
Research Services
Phone:  (215) 573 6709
Fax:    (215) 898 9708
email:  xxxxxx@pobox.upenn.edu

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================